Zobrazeno 1 - 10
of 506
pro vyhledávání: '"HUA SUI"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Classic Formulas (Jing fang) are considered the essence and authority of Traditional Chinese Medicine (TCM) due to their long history and proven efficacy. These formulas play a pivotal role in all kinds of different disease prevention and therapeutic
Externí odkaz:
https://doaj.org/article/14811454d6c24f2b958cc7ef31b8b7ca
Autor:
Hua Sui, Wanli Deng, Qiong Chai, Bing Han, Yuli Zhang, Zhenzhen Wei, Zan Li, Ting Wang, Jiling Feng, Man Yuan, Qingfeng Tang, Hongxi Xu
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 4, Pp 100901- (2024)
The density and composition of lymphocytes infiltrating colon tumors serve as predictive factors for the clinical outcome of colon cancer. Our previous studies highlighted the potent anti-cancer properties of the principal compounds found in Garcinia
Externí odkaz:
https://doaj.org/article/10aa83ee386f4478848b4541aefe3596
Autor:
Ning Tang, Yan Wang, Jiarui Miao, Yang Zhao, Yue Cao, Wentao Sun, Jingke Zhang, Hua Sui, Bing Li
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Tanshinone IIA (Tan-IIA) is the main bioactive component of Chinese herbal medicine salvia miltiorrhiza (Danshen). Sodium sulfonate of Tan-IIA is widely used in the treatment of cardiovascular and cerebrovascular diseases. Tan-IIA also has inhibitory
Externí odkaz:
https://doaj.org/article/8ee0e7150c5a44579f5b5ef77c6bcb26
Publikováno v:
Pharmacological Research - Modern Chinese Medicine, Vol 10, Iss , Pp 100347- (2024)
Introduction: Gastric cancer is one of the common malignancies worldwide, and drug resistance is a major factor contributing to the difficulty of treatment in gastric cancer. Zuojinwan (ZJW) has been found to exhibit a certain inhibitory effect on tu
Externí odkaz:
https://doaj.org/article/781fe3a8c1a14f1f80b1808580c921a9
Autor:
Xinnan Wu, Ruixiao Li, Qing Song, Chengcheng Zhang, Ru Jia, Zhifen Han, Lihong Zhou, Hua Sui, Xuan Liu, Huirong Zhu, Liu Yang, Yan Wang, Qing Ji, Qi Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/60127f0a845b426c942d83a3f8eb6f17
Autor:
Qing Song, Liu Yang, Zhifen Han, Xinnan Wu, Ruixiao Li, Lihong Zhou, Ningning Liu, Hua Sui, Jianfeng Cai, Yan Wang, Qing Ji, Qi Li
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/2efc35bee29a4a6581d42f5d6330ba91
Autor:
Hua Sui, Lu Zhang, Kaijuan Gu, Ni Chai, Qing Ji, Lihong Zhou, Yan Wang, Junze Ren, Limei Yang, Bimeng Zhang, Jing Hu, Qi Li
Publikováno v:
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-17 (2020)
Abstract Background Progression of Colorectal cancer (CRC) is influenced by single or compounded environmental factors. Accumulating evidence shows that microbiota can influence the outcome of cancer immunotherapy. T cell, one of the main populations
Externí odkaz:
https://doaj.org/article/4bc6a3aae08542c6be90c6de2e7b9532
Autor:
Qing Ji, Lihong Zhou, Hua Sui, Liu Yang, Xinnan Wu, Qing Song, Ru Jia, Ruixiao Li, Jian Sun, Ziyuan Wang, Ningning Liu, Yuanyuan Feng, Xiaoting Sun, Gang Cai, Yu Feng, Jianfeng Cai, Yihai Cao, Guoxiang Cai, Yan Wang, Qi Li
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-18 (2020)
Mechanisms regulating the formation of pre-metastatic niches remain poorly understood. Here, the authors show that ITGBL1-containing extracellular vesicles derived from primary colorectal cancer cells activate the production of inflammatory cytokines
Externí odkaz:
https://doaj.org/article/6c5236b721274f3a8bd1e08b42a1fdf5
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Methods: Articles on inflammatory tumor microenvironment were retrieved from the Web of Science Core Collection, and the characteristics of the articles were analyzed by CiteSpace software.Background: The inflammatory tumor microenvironment is an ess
Externí odkaz:
https://doaj.org/article/341a5fe9464d4ab39136539155d72f13
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262737 (2022)
IntroductionThe coronavirus disease 2019 (COVID-19), emerged in late 2019, was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The risk factors for idiopathic pulmonary fibrosis (IPF) and COVID-19 are reported to be common. Th
Externí odkaz:
https://doaj.org/article/1cf41ce8c82c4807a717a5b540be7364